Additional Resources

Section

NORD rare disease drug development ad.

Get Information about a Rare Disease

Use the form below to explore NORD's comprehensive rare disease database. Search for detailed information on rare diseases, including NORD's authoritative Rare Disease Reports and data from other reliable sources.
* = NORD Rare Disease Report

Interested in exploring the database in detail?
Click here to explore the database in alphabetical order.

facioscapulohumeral muscular dystrophy 1

The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.

Print

Disease Overview

Any facioscapulohumeral muscular dystrophy in which the cause of the disease is a mutation in the FRG1 gene.

Synonyms

  • FMD
  • FRG1 facioscapulohumeral muscular dystrophy
  • FSHD
  • FSHD1
  • FSHD1A
  • FSHMD1A
  • Landouzy-Dejerine muscular dystrophy
  • Landouzy-Dejerine muscular dystrophy facioscapulohumeral muscular dystrophy, infantile, included
  • facioscapulohumeral dystrophy with sensorineural hearing loss and tortuosity of retinal arterioles
  • facioscapulohumeral dystrophy with sensorineural hearing loss and tortuosity of retinal arterioles, included
  • facioscapulohumeral muscular dystrophy
  • facioscapulohumeral muscular dystrophy 1
  • facioscapulohumeral muscular dystrophy 1A
  • facioscapulohumeral muscular dystrophy caused by mutation in FRG1
  • facioscapulohumeral muscular dystrophy type 1
  • facioscapulohumeral muscular dystrophy, infantile
  • muscular dystrophy, facioscapulohumeral
  • muscular dystrophy, facioscapulohumeral, type 1
  • muscular dystrophy, facioscapulohumeral, type 1A
GARD Disease Summary

The Genetic and Rare Diseases Information Center (GARD) has information and resources for patients, caregivers, and families that may be helpful before and after diagnosis of this condition. GARD is a program of the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).

View report
OMIM

Online Mendelian Inheritance In Man (OMIM) has a summary of published research about this condition and includes references from the medical literature. The summary contains medical and scientific terms, so we encourage you to share and discuss this information with your doctor. OMIM is authored and edited at the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine.

View report
Sign Up for NORD News